Pre-Conference Workshop

Stephen A. Glazer, MD, FRCP(C ), FCCP
Internal Medicine
Critical Care Medicine
Diplomate of the American Board of Obesity Medicine

Medical Director, Bariatric Surgical Program
Humber River Regional Hospital
American College of Surgeons Level 1 Accredited Bariatric Center of Excellence

Medical Director, Greater Toronto Area Medical Bariatric Program
Humber River Regional Hospital/University Health Network

Assistant Professor, Department of Medicine
Division of Endocrinology and Metabolism
Queen's University

Lecturer, Department of Internal Medicine
University of Toronto

Dr. Stephen Glazer is a board certified specialist from the University of Toronto in Internal Medicine and Intensive Care Medicine. He is also a Diplomate of the American Board of Obesity Medicine.

In April 2010 he was appointed as the Medical Director for the Bariatric Surgical Program at Humber River Regional Hospital. He was instrumental in redeveloping their comprehensive bariatric surgical program. In that year, the bariatric surgical program was nominated as a Leading Practice by Accreditation Canada.

In 2012 Dr. Glazer was appointed as a the Director of the only hospital-based Medical Bariatric Program for the Greater Toronto Area, which has enjoyed great growth and development due to the significant contributions of its multidiscipline team members.

Dr. Glazer's commitment to the Obesity Epidemic is further displayed by his participation in many committees through the Ontario Bariatric Network and the Canadian Association of Bariatric Physicians and Surgeons. He has a strong interest in program development, quality care initiatives, and physician education.

He has personally been involved in direct patient care of over thousands of bariatric patients in the attempt to facilitate weight loss for improved overall health. His research interests include perioperative risk assessment and management as well as sleep apnea in the morbidly obese.

Dr. David Macklin, MD, CCFP
Director of Weight Management at Medcan
Medical Director of Weight Management, High Risk Special Pregnancy BMI Unit, Mount Sinai Hospital
Department of Family and Community Medicine, Faculty of Medicine, University of Toronto

Dr. Macklin is a physician trained in family practice at the University of Toronto. Dr. Macklin is the Director of the Weight Management Program at the downtown Toronto Medcan Clinic. Dr Macklin also runs the Weight Management Program at the Toronto Mount Sinai Hospital High Risk Pregnancy unit. Dr. Macklin has committed his career to the prevention and treatment of obesity and for over nine years has exclusively run multidisciplinary, evidence based weight management programs.

Joseph Shaban, MD, FRCPC, FACE, DABOM
Endocrinology and Metabolism
Adjunct Professor of Medicine, Western University
Medical Director, Regional Bariatric Assessment and Treatment Centre of Windsor
OMA Section Chair - Endocrinology and Metabolism

Dr. Shaban is a native of Windsor, Ontario and has practiced endocrinology and metabolism in Windsor since 1986. He received his undergraduate and postgraduate training at the University of Western Ontario.

Canadian and American Board certified in both Internal Medicine and Endocrinology and Metabolism, and a Fellow of the American College of Endocrinology, he is also a Diplomate of the American Board of Obesity Medicine.

He is currently the Ontario Medical Association Chair of the Section of Endocrinology and Metabolism. He is the current Head of the Subsection of Endocrinology at Windsor Regional Hospital, and Director of the Regional Bariatric Assessment and Treatment Centre in Windsor.

He has been a board member of the Ontario Bariatric Network since its inception, and currently chairs the Perioperative Task Force for the OBN. He is an adjunct professor of Medicine at Western University and has been involved as a primary investigator in numerous national and international medical studies.

Dr. David Macklin, MD, CCFP

Dr. Macklin is a physician trained in family practice at the University of Toronto. Dr. Macklin is the Director of the Weight Management Program at the downtown Toronto Medcan Clinic. Dr Macklin also runs the Weight Management Program at the Toronto Mount Sinai Hospital High Risk Pregnancy unit. Dr. Macklin has committed his career to the prevention and treatment of obesity and for over nine years has exclusively run multidisciplinary, evidence based weight management programs.

Tony Chetty, MD, FRCPC, MSc
Associate Professor
Pathology and Molecular Medicine
Division: Anatomical Pathology
Discipline Director, Clinical Chemistry and Immunology (HRLMP)
McMaster University

Dr. Tony Chetty obtained his Medical Degree in South Africa. He completed his Fellowship in Medical Biochemistry and Master's Degree in Health Research Methodology at McMaster University. His research interests have a focus on Clinical Trials, New Pharmacological approaches in Obesity and Type 2 DM Mx. He is currently an Associate Professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Chetty is the Medical Director of the Bariatric Medical Clinic at St. Joseph Healthcare Hamilton. He is also Chair of the Medical Program task force Committee of the Ontario Bariatric Network.

John Hagen, MD, FRCS(C)
Assistant Professor of Surgery, University of Toronto
Minimally Invasive Surgery Group
Chief of Surgery, Humber River Hospital
Surgical Director Bariatric Surgery

bio coming soon.

Stephen A. Glazer, MD, FRCP(C ), FCCP
Internal Medicine
Critical Care Medicine
Diplomate of the American Board of Obesity Medicine

Medical Director, Bariatric Surgical Program
Humber River Regional Hospital
American College of Surgeons Level 1 Accredited Bariatric Center of Excellence

Medical Director, Greater Toronto Area Medical Bariatric Program
Humber River Regional Hospital/University Health Network

Assistant Professor, Department of Medicine
Division of Endocrinology and Metabolism
Queen's University

Lecturer, Department of Internal Medicine
University of Toronto

Dr. Stephen Glazer is a board certified specialist from the University of Toronto in Internal Medicine and Intensive Care Medicine. He is also a Diplomate of the American Board of Obesity Medicine.

In April 2010 he was appointed as the Medical Director for the Bariatric Surgical Program at Humber River Regional Hospital. He was instrumental in redeveloping their comprehensive bariatric surgical program. In that year, the bariatric surgical program was nominated as a Leading Practice by Accreditation Canada.

In 2012 Dr. Glazer was appointed as a the Director of the only hospital-based Medical Bariatric Program for the Greater Toronto Area, which has enjoyed great growth and development due to the significant contributions of its multidiscipline team members.

Dr. Glazer's commitment to the Obesity Epidemic is further displayed by his participation in many committees through the Ontario Bariatric Network and the Canadian Association of Bariatric Physicians and Surgeons. He has a strong interest in program development, quality care initiatives, and physician education.

He has personally been involved in direct patient care of over thousands of bariatric patients in the attempt to facilitate weight loss for improved overall health. His research interests include perioperative risk assessment and management as well as sleep apnea in the morbidly obese.

Scott B. Gmora MD, FRCSC, FACS 
Minimally Invasive Gastrointestinal and Bariatric Surgery Director
Bariatric Clinic, St Joseph's Health Hamilton Assistant Professor
Department of Surgery McMaster University

Dr. Scott Gmora is an Assistant Professor of Surgery at McMaster University specializing in minimally invasive gastrointestinal and bariatric surgery. He completed his medical training at Queen's University receiving his Doctor of Medicine degree in 2002. He underwent residency training in general surgery at the University of Calgary and obtained specialty qualifications from the Royal College of Physicians and Surgeons of Canada and the American Board of Surgery in 2007. Dr. Gmora subsequently pursued 2 years of fellowship training in Critial Care and Trauma Surgery at the University of Miami's Ryder Trauma Center in Miami, Florida. In 2009, he completed an additional year of fellowship training in minimally invasive GI and bariatric surgery under Dr. Julio Teixeira at Columbia University's St. Luke-Roosevelt Hospital in New York. Dr. Gmora serves as the Ontario Bariatric Network's provincial lead for the Primary Care Engagement Task Force. He is also the Clinical Teaching Unit (CTU) Director for surgical residents at St. Joseph's Healthcare.

Stephen A. Glazer, MD, FRCP(C ), FCCP
Internal Medicine
Critical Care Medicine
Diplomate of the American Board of Obesity Medicine

Medical Director, Bariatric Surgical Program
Humber River Regional Hospital
American College of Surgeons Level 1 Accredited Bariatric Center of Excellence

Medical Director, Greater Toronto Area Medical Bariatric Program
Humber River Regional Hospital/University Health Network

Assistant Professor, Department of Medicine
Division of Endocrinology and Metabolism
Queen's University

Lecturer, Department of Internal Medicine
University of Toronto

Dr. Stephen Glazer is a board certified specialist from the University of Toronto in Internal Medicine and Intensive Care Medicine. He is also a Diplomate of the American Board of Obesity Medicine.

In April 2010 he was appointed as the Medical Director for the Bariatric Surgical Program at Humber River Regional Hospital. He was instrumental in redeveloping their comprehensive bariatric surgical program. In that year, the bariatric surgical program was nominated as a Leading Practice by Accreditation Canada.

In 2012 Dr. Glazer was appointed as a the Director of the only hospital-based Medical Bariatric Program for the Greater Toronto Area, which has enjoyed great growth and development due to the significant contributions of its multidiscipline team members.

Dr. Glazer's commitment to the Obesity Epidemic is further displayed by his participation in many committees through the Ontario Bariatric Network and the Canadian Association of Bariatric Physicians and Surgeons. He has a strong interest in program development, quality care initiatives, and physician education.

He has personally been involved in direct patient care of over thousands of bariatric patients in the attempt to facilitate weight loss for improved overall health. His research interests include perioperative risk assessment and management as well as sleep apnea in the morbidly obese.

Pavel Hamet, O.Q., MD, PhD, FRCPC, FAHA, FRSM, FCAHS

Dr. Hamet holds a Canada Research Chair in Predictive Genomics. He is Professor of Medicine at Université de Montréal and of Experimental Medicine at McGill University, as well as a Visiting Professor at the First Faculty of Medicine at Charles University, Prague, Czech Republic. He is currently Chief of Gene Medicine Services at the Centre Hospitalier de l’Université de Montréal. He is also President of Medpharmgene, an academic biotechnology society devoted to the conduct of high-level science results-oriented clinical research programs. He has received many honors from the American Heart Association, the Canadian Cardiovascular Society, Hypertension Canada, the Japan Vascular Disease Research Foundation Society, the Czech Academy of Science and La Societé Francophone de Diabète. He received the prestigious Wilder Penfield Award and National Order from Quebec Government for which he serves as Commissioner of Ethics in Science and Technology. His research is targeting the development of genetic-based diagnostic/predictive tools for cardiovascular and renal complications of diabetes and hypertension in order to improve therapeutic and preventive interventions in patients.

Marie-Philippe Morin, MD, FRCPC
General Internal Medicine specialist
Bariatric Medicine fellowship

Dr Marie-Philippe Morin works as a General Internal Medicine Specialist at the Quebec Heart and Lung Institute and is an Assistant Professor affiliated to Laval University. She completed her Doctorate in Medicine and her residency in General Internal Medicine at Laval University. In 2016, she achieved a one-year fellowship in bariatric medicine through the University of Ottawa at the Ottawa Hospital Bariatric Centre of Excellence and LEAF Weight Management Clinic. She is also a diplomate of the American Board of Obesity Medicine. Her specialty interests are cardiovascular risk factor management associated with obesity and the management of medical/nutritional complications after bariatric surgery, particularly duodenal switch.

Presentation Overview
The counter-regulating mechanisms to defend body weight make weight loss and weight maintenance challenging for patients with obesity. Consequently, patients often need additional tools in conjunction with lifestyle modification to manage this chronic disease. Medication are tools that clinicians can use to help patients manage obesity and its comorbidities. Naltrexone/Bupropion (Contrave) is a new anti-obesity medication now approved in Canada since 2018.

Learning Objectives

1. To explain the mechanism of action of Naltrexone/Bupropion on the brain for inducing weight loss. 
2. To understand the indications and contraindications of Naltrexone/Bupropion. 
3. To review the safety data, the drugs interactions and the side effects related to the medication. 
4. To review how to start Naltrexone/Bupropion regarding dose titration and how to follow patients who are taking this medication

Louis J. Aronne, MD, FACP 
Weill Professor of Metabolic Research
Weill Cornell Medical College
Medical Director
Comprehensive Weight Control Center, New York, NY

Louis J. Aronne, MD, FACP, DABOM is a leading authority on obesity and its treatment. He is the Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College where he directs the Comprehensive Weight Control Center, a state-of-the-art, multidisciplinary obesity research, and treatment center with one of the country’s few Obesity Medicine fellowship programs. He has an adjunct Associate Professor of Clinical Medicine appointment at Columbia University. Dr. Aronne is Founder and CEO of BMIQ, a cloud-based weight management system that enables high quality behavioral management of obesity by health care providers. Dr. Aronne graduated Phi Beta Kappa from Trinity College with a BS in biochemistry and from Johns Hopkins University School of Medicine. He completed his internship and residency at Albert Einstein College of Medicine, followed by a Kaiser Foundation Fellowship at Weill-Cornell. He is a member of the AOA Medical Honor Society.

Dr. Aronne is former president of the Obesity Society and past Chairman of the American Board of Obesity Medicine. He has performed more than 50 clinical trials of novel obesity treatments, authored more than 100 papers and book chapters on obesity and edited the NIH Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity. He served as a consultant in the development of the Veterans Administration MOVE program, the nation’s largest medically based weight control program. Dr. Aronne has won several awards for medical teaching. Since 2001 he has been ranked in Castle-Connelly’s Top Doctors in NY directory as a specialist in obesity and internal medicine.

Scott Kahan, MD, MPH
Director, National Center for Weight and Wellness

Scott Kahan, MD, MPH, is a physician trained in both clinical medicine and public health. He received his undergraduate degree in bioengineering from Columbia University, his medical degree from Medical College of Pennsylvania, and his residency training at Johns Hopkins University. His clinical practice specializes in obesity medicine, and he serves as Director of a multidisciplinary obesity medicine clinic in Washington, DC. In addition to his clinical practice, Dr. Kahan works as a public health physician specializing in obesity prevention and treatment. He serves as Medical Director for the George Washington University Strategies to Overcome and Prevent (S.T.O.P.) Obesity Alliance, a coalition of 100 organizations that drive innovative and practical strategies to address obesity.

Dr. Kahan serves on Faculty at Johns Hopkins Bloomberg School of Public Health, George Washington University School of Medicine and Health Sciences, and George Washington University Milken Institute School of Public Health.  He teaches several courses on obesity, nutrition, public health, and health behavior change to medical, graduate, and undergraduate students, and he leads numerous seminars and continuing medical education symposia on obesity management, nutrition, behavioral medicine, and preventive medicine. He has published more than 100 scientific articles, textbooks, and textbook chapters, and serves as peer reviewer for more than 50 scientific journals and organizations. He is Chair of The Obesity Society Clinical Committee and The Obesity Society Standards of Care committee. He serves on the Boards of Directors for the American Board of Obesity Medicine, the Obesity Action Coalition, and the Obesity Treatment Foundation. He has received numerous clinical, teaching, and advocacy awards, including the 2017 Clinician of the Year by The Obesity Society, 2016 Healthcare Professional Advocate of the Year by the Obesity Action Coalition, and Outstanding Contribution Award by the Academy of Nutrition and Dietetics. 

Dr. Kahan has advised the White House, U.S. Congress, FDA, and several Surgeons General. He is a member of the Institute of Medicine Committee on Obesity Solutions, and has served on committees for the National Institutes of Health and Centers for Medicare and Medicaid Services

Presentation overview
This session will focus on practical clinical strategies for use of obesity pharmacotherapy, in general, and specifically naltrexone-bupropion fixed dose combinations, which is the newest approved medication for obesity treatment in Canada. Via case studies and presentation of commonly-asked questions from clinical providers, Dr. Kahan will offer family doctors and obesity clinicians insights on how they can use medication as part of obesity management. 

Learning Objectives
At the completion of this presentation, participants should be able to

1. Feel comfortable using obesity pharmacotherapy, including naltrexone-bupropion fixed dose combination, in their clinical practices
2. Appreciate several characteristic patient types that may be particularly good candidates for use of naltrexone-bupropion fixed dose combination
3. Be familiar with practical uses of naltrexone-bupropion fixed dose combination alongside behavioral weight management counseling